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Abstract 23 
Salivary glands in elderly individuals commonly exhibit morphological 24 
changes and dysfunction resulting in xerostomia. Long-term (4-week) 25 
drinking of whey prevented and/or restored age-dependent decline of 26 
salivary volume and protein concentration, and atrophy of sublingual glands 27 
(SLGs) significantly in 88-week-old rats. The transcripts of 42 genes were 28 
up-regulated and 7 genes were down-regulated by more than 1.5-fold change 29 
with FDR≦ 0.1 after whey-drinking. The expression levels of genes 30 
associated with salivary proteins and tissue repair were significantly 31 
increased, while those associated with lipid metabolism were decreased. 32 
Venn diagram analysis revealed that expressions of 13 genes, including 33 
Tcfap2b and Abpa, were induced significantly by whey-drinking. 34 
Furthermore, secretory protein levels in SLGs and saliva were revealed by 35 
immunoblot analysis. This is the first study to report that 36 
whey-administration can prevent and/or restore age-dependent atrophy and 37 
functional decline of SLGs in relation to gene expression and thus may serve 38 
as a functional food ingredient. 39 
Keywords: 40 
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Abbreviations: AR, androgen receptor; AP-2, activating protein-2; FDR, false 46 
discovery rate; SDS-PAGE, sodium dodecyl sulphate-polyacrylamide gel 47 
electrophoresis; SLGs, sublingual glands; OC, water-drinking elderly rat; OJ, 48 
whey-drinking elderly rat; PRP, proline-rich protein; qRT-PCR, quantitative 49 
reverse transcription-polymerase chain reaction 50 
 51 
1. Introduction 52 
Xerostomia, which is also referred to as dry mouth, is a common problem among the 53 
elderly (Gonsalves et al., 2008; Sun et al., 2013). Xerostomia leads to infectious 54 
conditions, such as periodontal disease and caries, in the oral cavity (Sreebny, 2000; 55 
Guggenheimer & Moore, 2003); these, in turn, lead to an increased risk of 56 
atherosclerosis, cardiovascular disease (Meurman et al., 2004) and diabetes (Darre et 57 
al., 2008). Thus, xerostomia can result in not only oral diseases, but also systemic 58 
diseases. In addition, xerostomia causes dysphagia (Guggenheimer & Moore, 2003), 59 
resulting in a reduced quality of life, and increases susceptibility to aspiration 60 
pneumonia (Kikutani et al., 2015), which can cause mortality. 61 
   Salivary glands consist of three major glands, i.e., the parotid glands, 62 
submandibular glands and sublingual glands (SLGs), as well as numerous minor glands. 63 
In the unstimulated condition, the parotid glands have a very low secretion rate. In 64 
contrast, the submandibular glands and SLGs secrete relatively more saliva under 65 
unstimulated conditions (Proctor & Carpenter, 2007). The glands are innervated by 66 
autonomic nerves (Proctor & Carpenter, 2007). Noradrenaline released from 67 
sympathetic nerves stimulates salivary secretion through 1- and -adrenoceptors. 68 
Activation of 1-adrenoceptors induces fluid secretion from the salivary glands via an 69 
increase in the intracellular concentration of calcium, while activation 70 
of-adrenoceptors induces protein secretion from the glands via the activation of 71 
protein kinase A. Acetylcholine released from parasympathetic nerves interacts with 72 
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the M1- and M3-muscarinic cholinergic receptors to induce fluid secretion from the 73 
salivary glands via activation of the calcium signaling pathway (Proctor & Carpenter, 74 
2007). An age-related decrease in salivary secretion has been recognized during both 75 
the unstimulated condition (Ship et al., 2002; Pan et al., 2009) and the stimulated 76 
condition (Inoue et al., 2003; Choi et al., 2013). 77 
   Whey, a co-product of cheese manufacturing, can supply not only nourishment, but 78 
also many biologically active components to humans. For example, whey protein 79 
stimulates protein synthesis in relation to gene expression in skeletal muscle after 80 
exercise (Kanda et al., 2013; Kanda et al., 2014) as well as the accretion of muscle 81 
protein in the elderly (Pennings et al., 2011). In addition, it has been shown to reduce 82 
tumorigenesis in the rat colon (Xiao et al., 2005). Whey protein also has an 83 
insulinotropic effect in both type 1 (Hwang et al., 2012) and type 2 (Pasin & Comerford, 84 
2015) diabetes. Beta-lactoglobulin, a major component of whey, acts as a molecular 85 
carrier and alters the bioaccessibility of linoleate/linoleic acid, reducing the risk of 86 
cardiovascular disease (Le Maux et al., 2012). Thus, whey is a functional food with 87 
possible therapeutic applications. 88 
   To the best of our knowledge, no study has assessed the impact of whey on the aging 89 
process in the salivary glands; thus, in the present study, we examined the effects of 90 
whey supplementation on age-related changes in morphology, gene expression and 91 
function of rat salivary glands. We found a new function of whey that recover 92 
age-dependent atrophy and functional decline of the SLGs in relation to gene 93 
expression. 94 
 95 
2. Materials and methods 96 
2.1. Experimental animals and collection of saliva 97 
Eight-week-old male Wistar rats (body weight: 211 ± 18 g) were purchased from SLC, 98 
Inc. (Shizuoka, Japan) and given a standard laboratory chow (MF; Oriental Yeast, 99 
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Tokyo, Japan). At the age of 12-week (young, body weight: 294 ± 6 g) and 84-week 100 
(elderly, body weight: 491 ± 5 g), rats were divided into water-drinking group and 101 
whey-drinking group. One young group and one elderly group were provided water ad 102 
libitum for 4 weeks and one young group and one elderly group were provided cheese 103 
whey from Jersey cattle (donated by Ooyama Ranch Inc., Kagawa, Japan) ad libitum for 104 
4 weeks. Compositional characteristics of whey are in Supplementary table1. They were 105 
maintained in a temperature-controlled environment (22 ± 2°C) with a 106 
12-h-light/12-h-dark cycle in accordance with the guidelines established by the Animal 107 
Care Committee of Tokushima University Graduate School. Salivary glands were 108 
rapidly removed from rats sacrificed by a blow to the head under chloroform-inhalation. 109 
Cevimeline (10.0 mg/kg)(Daiichi-Sankyo Pharmaceutical Co. Tokyo, Japan)  was 110 
injected intraperitoneally into rats. During the first 30 min after cevimeline-injection, 111 
saliva was collected by pipette.     112 
 113 
2.2. Histological analysis 114 
Salivary glands for light microscopic examination were fixed by immersion in 10% 115 
phosphate-buffered formalin and then processed for paraffin sections. Routinely, 5-m 116 
sections were cut and stained with hematoxylin and eosin. 117 
 118 
2.3.  DNA microarray experiments 119 
Four rats were randomly selected from each of the water-drinking and whey-drinking 120 
groups. The total RNA was isolated from the SLGs of the rats using the RNeasy Mini 121 
Kit (Qiagen GmbH, Hilden, Germany) and QIAcube (Qiagen GmbH). RNA purity was 122 
assessed by the ratio of the absorbance at 260 and 280 nm measured using a NanoDrop 123 
ND-1000 spectrophotometer (NanoDrop Technologies, Inc., Wilmington, DE, USA) and 124 
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was examined using an Agilent2100 Bioanalyzer (Agilent Technologies, Santa Clara, 125 
CA, USA). First-strand cDNA was synthesized from 400 ng of total RNA using the 126 
Whole Transcript (WT) Expression Kit (Ambion, Austin, TX, USA) according to the 127 
supplier’s protocols. The resultant cDNA was fragmented and end-labeled with the 128 
GeneChip® WT Terminal Labeling Kit (Affymetrix, Santa Clara, CA, USA). Then, 5.5 g 129 
of the fragmented and labeled DNA target was hybridized to the Affymetrix GeneChip® 130 
Rat Gene 1.0 ST Array (Affymetrix) at 45°C for 17 h in a GeneChip® Hybridization Oven 131 
640 (Affymetrix) according to the recommended experimental protocols provided by the 132 
supplier. This array comprised more than 722,254 unique 25-mer oligonucleotide 133 
features constituting more than 27,342 probe sets for known and unknown genes. The 134 
hybridized arrays were washed and stained in a GeneChip® Fluidics Station 450 and 135 
scanned with a GeneChip® Scanner 3000 7G (Affymetrix), and GEL files were generated 136 
for each array. In each comparison experiment, the intensity levels for the two chips 137 
were normalized by dye swap and flag treatments using Affymetrix Expression Console 138 
Software (Affymetrix). 139 
 140 
2.4. Analysis of microarray data 141 
Microarray data were imported into GeneSpring GX version 12 (Agilent, Santa Clara, 142 
CA, USA). This software package allows multi-filter comparison using data from 143 
different experiments to perform normalization and the generation of restriction lists 144 
and functional classifications of the differentially expressed gene. The signal intensities 145 
of the selected genes that were up-regulated or down-regulated by at least 1.5-fold when 146 
compared to a control group were extracted by this software and a false discovery rate 147 
(FDR) value was calculated using the Significant Analysis of Microarrays method 148 
(Tusher et al., 2001). FDR value was rounded off a number of the decimal point third 149 
position and the expression change was taken as informative when FDR value was ≦150 
0.1. 151 
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 152 
2.5. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR). 153 
The differential expression of selected genes was assessed by qRT-PCR. cDNA was 154 
synthesized from 500 ng of RNA extracted from the SLGs using the High Capacity 155 
cDNA Reverse Transcription Kit (Applied Biosystems, Foster, CA, USA). cDNA was 156 
amplified using the StepOnePlus™ Real-Time PCR System (Applied Biosystems). The 157 
primers listed in Supplementary table 2 were designed using Primer-BLAST software 158 
(NCBI). Amplified cDNA was detected using the Power SYBR Green PCR Master Mix 159 
Reagent kit (Applied Biosystems). The PCR conditions were as follows: incubation for 160 
10 min at 95°C, followed by 40 cycles of denaturation for 10 s at 95°C, annealing for 15 s 161 
at 60°C and extension for 15 s at 72°C. The target and reference genes were amplified 162 
on the same plate. A non-template control was included for all of the primer pairs in 163 
each run. Data were analyzed using StepOnePlus™ software (version 2.3; Applied 164 
Biosystems). The expression values were normalized to that of -actin as an endogenous 165 
control as it showed little variation in expression across the sample sets. The mean fold 166 
change of expression in the SLGs of whey-drinking rats compared with that of 167 
water-drinking rats using the 2-ΔΔCT method. Analyses were performed in triplicate 168 
using RNA samples from at least three different rats. 169 
 170 
2.6. Gel electrophoresis and Western blot analysis. 171 
SLGs and saliva samples were dissolved with Laemmli sample buffer (Bio-Rad, 172 
Hercules, CA, USA) and the samples with 15 g of protein or 15 l were subjected to 173 
SDS-polyacrylamide gel electrophoresis (PAGE) on 10%, 12.5% and 15% gradient gels. 174 
For immunoblot analysis, the separated proteins were transferred onto a nitrocellulose 175 
transfer membrane (Hybond ECL; Amersham Biosciences, Little Chalfont, UK). 176 
Membranes were blocked overnight with 0.1% Tween 20 in Tris-buffered saline pH 7.4. 177 
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The blots were then probed with rabbit anti-basic proline-rich protein (PRP, 1:10 000; a 178 
kind gift from Prof. David Castle, University of Virginia (Castle & Castle, 1993)), rabbit 179 
anti-cystatin S (1:500, Sino Biological Inc., Beijing, China), or rabbit anti-amylase 180 
(1:1500, Calbiochem, Darmstadt, Germany) antibody. The membranes were washed 181 
with Tris-buffered saline containing 0.1% Tween 20 and incubated with horseradish 182 
peroxidase-linked donkey anti-rabbit IgG, whole Ab (1:5000, GE Healthcare, 183 
Piscataway, NJ, USA) for 1 h. Immunoblots were processed using enhanced 184 
chemiluminescence (ECL) (Amersham) and the signals were visualized on a Chemi Doc 185 
apparatus (Bio-Rad, Hercules, CA, USA). The bands were quantified using Quantity 186 
One software (Bio-Rad).  187 
 188 
2.6. Statistical analysis 189 
Data are expressed as the mean value ± standard error. To test for statistically 190 
significant differences between two groups, a paired Student’s t-test was used for 191 
biochemical tests, qRT-PCR and Western blot analysis. A p value of less than 0.05 was 192 
considered to be statistically significant. In microarray analysis, Moderated t-test was 193 
used.  194 
 195 
3. Results 196 
3.1. Animals 197 
Body weight at the beginning and end of the study, drinking volume, salivary gland 198 
weight and salivary protein concentration were not significantly different between the 199 
water-drinking (control) young rats and the whey-drinking young rats (Table 1). In 200 
elderly rats, body weight at the beginning and end of the study, drinking volume, 201 
parotid and submandibular gland weight were not also significantly different between 202 
the water-drinking group and the whey-drinking group. SGL weight, salivary volume 203 
and salivary protein concentration were significantly higher in whey-drinking elderly 204 
rats compared to water-drinking elderly rats.  205 
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 206 
3.2. Morphology 207 
To evaluate the effect of whey-administration on the morphology of the SLGs, histology 208 
was performed on SLGs tissue sections using hematoxylin and eosin staining (Fig. 209 
1A-D). Atrophy was detected in the SLGs of elderly water-drinking rats (Fig. 1C), but 210 
not in the SLGs of the younger water-drinking rats (Fig. 1A). Whey-drinking did not 211 
affect the morphology of the SLGs in the younger whey-drinking rats (Fig. 1B), and 212 
age-dependent atrophy of the SLGs was not detected in the elderly whey-drinking rats 213 
(Fig. 1D). These results suggested that whey-drinking prevented and restored 214 
age-dependent atrophy of the SLGs. 215 
 216 
3.3. Microarray 217 
Microarray chips are a powerful technology that allows the simultaneous measurement 218 
of the expression levels of thousands of genes. The resulting expression profiles have led 219 
to dramatic advances in the understanding of cellular processes at the molecular level. 220 
Total RNA was isolated from the SLGs of eights rats in the 84-week-old group; samples 221 
from the rats in the water-drinking group and the whey-drinking group (n = 4 each) 222 
were compared. Of 27,342 genes, 42 genes were up-regulated by at least 1.5-fold change 223 
with FDR ≦0.1 in the whey-drinking group when compared to the water-drinking 224 
group (Table 2). The up-regulated genes included those encoding major salivary families 225 
of specific secretory proteins (Scarano et al., 2010), i.e., PRP genes (Prp2, Prol1, Prog1, 226 
Prp15), cystatin genes (Cyss, Vegp2), and amylase gene (Amy1a). The expression of 227 
tissue-specific genes, i.e., kallikreins (Klks3, Klk1c10, Klk1) and kallikrein-related 228 
genes (Ton, Klk1l, Klk1c10l2), was induced in the whey-drinking group. The levels of 229 
androgen-binding protein gene (Abpa) and androgen-related protein genes (Smr3a) 230 
were also increased in the whey-drinking group when compared to the water-drinking 231 
group. 232 
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Of 27,342 genes, 7 genes were down-regulated by at least 1.5-fold change with FDR 233 
≦0.1 in the whey-drinking group when compared to the water-drinking group (Table 3). 234 
The down-regulated genes included those associated with lipid metabolism, 235 
transcription regulation, cancer and senescence. 236 
   In order to investigate the common genes showing fluctuating expression levels in 237 
the four sets, Venn diagram analysis was performed (Fig. 2 A). Each set comprised 238 
microarray data from the whey-drinking group vs. those from the water-drinking group. 239 
In the first (Fig. 2 B-a), second (Fig. 2 B-b), third (Fig. 2 B-c) and fourth (Fig. 2 B-d) sets, 240 
the whey-drinking group showed 512, 238, 473, and 938 entities with more than a 241 
1.5-fold difference when compared to the water-drinking group, respectively. Among the 242 
four sets, 21 entities were overlapped (Fig. 2A). Because this array comprised more than 243 
722,254 unique 25-mer oligonucleotide features constituting more than 27,342 probe 244 
sets, 21 entities represent 13 genes. The 13 genes are listed in Table 4. Transcription 245 
factor AP-2 gene (Tcfap2b), which is a salivary gland-specific transcription factor gene 246 
(Hu & Gallo, 2010), and androgen-binding protein alpha (Abpa), which is a pheromone 247 
gene (Karn & Laukaitis, 2009), are induced by whey-administration, suggesting that 248 
androgen-dependent transcription programs functioned together with a tissue-specific 249 
collaborating factor, AP-2, in whey-drinking rats. 250 
 251 
3.4. qRT-PCR 252 
In order to verify the results of the microarray analysis, selected genes with an 253 
expression level that differed by at least 1.5-fold between the whey-drinking group and 254 
the water-drinking group were confirmed using qRT-PCR. Whey administration 255 
induced an approximately 15-fold up-regulation of the Cyss and Prb1 genes and an 256 
approximately 4-fold up-regulation of the Tcfap2b and Abpa. In addition, whey 257 
administration induced a 2-fold up-regulation of the Amy1a and Lyz2 genes. All of the 258 
results of qRT-PCR analysis were consistent with the microarray expression profiles 259 
(Fig. 3).  260 
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 261 
3.5. Western blotting 262 
Western blot analysis was used to quantify the changes in levels of selected proteins in 263 
the SLGs (Fig. 4 A) and saliva (Fig. 4 B) in response to whey-drinking. PRP, cystatin S 264 
and amylase levels in the SLGs were increased by 3-, 4.5- and 5-fold, respectively, in the 265 
whey-drinking group in comparison with the water-drinking group (Fig. 4A). Salivary 266 
PRP, cystatin S and amylase levels were increased by 2.5- to 3-fold in the whey-drinking 267 
group in comparison with the water-drinking group (Fig. 4B). These results suggested 268 
that whey-drinking prevented and/or restored the age-dependent functional decline in 269 
SLGs and saliva. 270 
 271 
4. Discussion 272 
This is the first study to report that whey prevented and recovered age-dependent 273 
atrophy and functional decline of the salivary glands in relation to gene expression. 274 
Saliva is a unique body fluid that continually bathes the oral cavity and larynx to aid in 275 
essential functions, such as mastication, oral microbial defense, gustation, lubrication, 276 
speech, deglutition, digestion, mineralization of teeth, and the protection of mucosal 277 
tissues (Humphrey & Williamson, 2001; Amerongen & Veerman, 2002). The 278 
fundamental functions of saliva are strictly connected to its composition that consists in 279 
a complex hypotonic aqueous solution containing proteins, peptides, enzymes, hormones, 280 
sugars, lipids and others (Messana et al., 2008). Recent proteomic approaches have 281 
revealed that more than 2,400 proteins are contained in saliva (Castagnola et al., 2011). 282 
PRPs account for more than 60% of the weight of the total salivary proteome 283 
(Messana et al., 2008). They have been divided into three classes: basic PRP, acidic 284 
PRP, and glycosylated PRP. Among the PRP genes induced by whey-drinking, Prb1 285 
belongs to the basic PRP group, Prp2 and Prp15 belong to the acidic PRP group and 286 
Prpg1 belongs to the glycosylated PRP group. According to our results, the levels of 287 
PRPs were also increased in the SLGs and saliva by whey-drinking. Packaging of PRPs 288 
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into the secretory granules of salivary glands may be important in the reduction of 289 
osmotic activity during granule maturation (Castle & Castle, 1993). One of the 290 
biological roles of salivary PRPs is to protect epithelial cells against the toxic effects of 291 
food (Messana et al., 2008). 292 
   Cystatins act as an inhibitor of cysteine proteinase and belong to an evolutionally 293 
related superfamily (Shaw & Chaparro, 1999). Cystatin S accounts for 8% of the weight 294 
of salivary proteins (Messana et al., 2008). Von Ebner gland proteins (Vegp2) also act as 295 
an inhibitor of cysteine proteinase (Amerongen & Veerman, 2002). Coupled with the 296 
high level of Cyss gene expression in the whey-drinking group, the expression of 297 
cystatin S protein also increased in the SLGs and saliva due to whey administration. 298 
Salivary cystatin S plays a role in controlling proteolytic activity, either from the host or 299 
from microorganisms, to protect the oral cavity. 300 
Salivary amylase accounts for approximately 20% of the weight of salivary proteins 301 
(Messana et al., 2008). Amylase (Amy1a, salivary type) was induced in the SLGs of the 302 
whey-drinking group when compared to those of the water-drinking group. 303 
Kallikreins, which are serine proteases, are secreted as inactive zymogen granules 304 
and are activated by the cleavage of an N-terminal peptide (Yousef & Diamandis, 2003). 305 
Approximately 13 kallikreins have been identified in rat. The expression of kallikrein 306 
genes is tissue-specific. Klk1, which is mainly expressed in the salivary glands, kidney 307 
and pancreas, plays a constitutive and/or developmental role in glands or renal 308 
physiology (Swift et al., 1982; Clements et al., 1990). Klk1 and Klk1-related peptidase 309 
genes (Klks3, Klk1c10, Klk1l, GK11, Klk1b21, Klk1c10l2) were up-regulated by 1.6- to 310 
11.5-fold in the SLGs of the whey-drinking group when compared to those of the 311 
water-drinking group. Tonin (Ton) is also a serine proteinase from the kallikrein family; 312 
it cleaves angiotensin II from angiotensin I, from the synthetic tetradecapeptide 313 
corresponding to the N-terminal segment of angiotensinogen and directly from 314 
angiotensinogen (Boucher et al., 1977; Pacheco Dda et al., 2013). There is 75% homology 315 
between the sequence of the -subunit of nerve growth factor and tonin (Lazure et al., 316 
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1981). Tonin isolated from rat submandibular glands has also been reported to be very 317 
closely related to the epidermal growth factor-binding protein (Lazure et al., 1981). 318 
These results suggest that kallikrein family proteins induced by whey-administration 319 
may prevent and/or restore age-dependent atrophy of SLGs. 320 
   Androgen-binding protein (Abpa), which is a member of the secretoglobin family 321 
(Jackson et al., 2011), is expressed in the SLGs as well as the submandibular and 322 
parotid glands, and is then secreted into the saliva (Vandewege et al., 2013). The 323 
secretoglobin family has an important role in modulating anti-inflammation, tissue 324 
repair, and tumor suppression and activation (Jackson et al., 2011). This family of 325 
proteins has also been reported to repair dry eye (Versura et al., 2010). 326 
   The AP-2 family of transcription factors consists of five members, AP-2, AP-2, 327 
AP-2, AP-2 and AP-2each encoded by a separate gene (Eckert et al., 2005). 328 
Administration of whey induced expression of the AP-2 gene, but not the AP-2, AP-2, 329 
AP-2 or AP-2 genes Supplementarytable 3 AP-2 is known as a tissue-specific 330 
collaborating factor and plays a critical role in the androgen-dependent transcription 331 
program (Hu & Gallo, 2010; Pihlajamaa et al., 2014). 332 
   Cyss, one of the up-regulated genes in this study, has a potential AP-2 binding site 333 
(－194，TGGGGA) and androgen receptor (AR) response element which is the same as 334 
the glucocorticoid/progesterone response element in 5’-flanking region (Shaw & 335 
Chaparro, 1999). In androgen-dependent transcription programs, AR-binding is not 336 
sufficient to activate or repress the transcription and collaborating factors are necessary 337 
as AR modulators. More than 90% of up- or down-regulated genes by 338 
whey-administration in this experiment have an AR response element and AP-2 339 
binding site in their promoter regions, suggesting that enhancement of AR-binding and 340 
promoter binding by AP-2 regulated the expression of genes associated with salivary 341 
proteins or lipid metabolism in salivary glands.  342 
   Dietary caloric restriction manipulates aging, maintaining health, and function 343 
(Roth & Ingram, 2015). Regardless of a caloric restriction, administration of whey alters 344 
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gene expression in elderly salivary glands and then prevents and/or restores 345 
age-dependent dysfunction of salivary glands, leading to maintain systemic health.   346 
   347 
5. Conclusion 348 
Comprehensive analysis of genetic profiles revealed that oral administration of whey 349 
induced the expression of Abpa and Tcfap2b in SLGs of elderly rats. Androgens 350 
transported through the cytoplasm by androgen binding proteins interact with AR in 351 
nuclei. AR and AP-2 beta binding to promoter of genes encoding salivary proteins and 352 
salivary gland homeostasis initiates the transcriptional responses. Through this process, 353 
bioactive components of whey restore atrophy and dysfunction of salivary glands in 354 
aged rats. Kallikrein family including tonin may prevent and/or restore age-dependent 355 
atrophy of SLGs. To our knowledge, this is the first study to report that 356 
whey-administration alters gene expression, thereby preventing and/or restoring 357 
age-dependent atrophy and functional decline in the salivary glands of aged rats.  358 
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Figure Legends 507 
Fig. 1. Effect of whey- or water-drinking on the morphology of the sublingual glands 508 
(SLGs). Eight-week-old rats were given water (A) or whey (B) for 1 month. 509 
Eighty-four-week-old rats were given water (C) or whey (D) for 1 month. Bar, 10 510 
m. 511 
   512 
Fig. 2. Venn diagram and scatterplot analysis. Using a Venn diagram (A), overlapping 513 
genes were analyzed among four sets. One set comprised microarray data from a 514 
whey-drinking elderly rat (OJ) vs. those from a water-drinking elderly rat (OC). 515 
Scatterplot analysis (B) of genes that were differentially expressed by more than 516 
1.5-fold between the whey-drinking group and the water-drinking group. Four 517 
separate experiments were performed. In B-a, B-b, B-c, and B-d there were 512, 238, 518 
473, and 938 entities, respectively, with more than a 1.5-fold difference between the 519 
whey-drinking group and the water-drinking group.  520 
 521 
Fig.3. Effects of whey-drinking on the mRNA levels analyzed by qRT-PCR. The total 522 
RNA obtained from SLGs from 84-week-old rats given water or whey. Mean values 523 
with standard errors of relative mRNA expression compared to water-drinking 524 
group are shown. n=3, *p<0.05, **p<0.01, ***p<0.001.  525 
  526 
Fig.4. Effects of whey-drinking on proline-rich protein (PRP), cystatin S, and amylase 527 
levels in SLGs and saliva. SLGs (A) and saliva (B) samples were treated with 528 
Laemmli sample buffer and SLGs sample with 15 g of protein or 15 l saliva were 529 
subjected to SDS-PAGE. The proteins were transferred to a nitrocellulose 530 
membrane and immunoblotted with anti-PRP antibody (a), anti-cystatin S antibody 531 
(b), and anti-amylase antibody (c). A typical western blot is shown in photography. 532 
Densitometric analysis was expressed in graphs as the relative amount of 533 
chemiluminescence in whey-drinking group vs. water-drinking. Mean values with 534 
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of three separate experiments standard error were shown. n=3, *p<0.05, **p<0.01, 535 
***p<0.001.      536 
 537 
FIG.1 
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Table 1. Body weight, drinking volume, salivary gland weight, salivary volume and salivary 
protein concentration levels in water-drinking group and whey-drinking group. 
 
 Young rats Elderly rats 
Water Whey Water Whey 
Body weight Initial 293±3 
 (12-week) 
294±6 
(12-week) 
494±5 
(84-week) 
489±5 
(84-week) 
Final 327±17 
(16-week) 
315±1 
(16-week) 
489±5 
(88-week) 
479±2 
(88-week) 
Drinking volume (g/day) 22.3±0.5 24.1±1.4 25.7±0.8 27.1±0.5 
Salivary gland  
weight (mg) 
Parotid gland 196±4 197±8 152±7 149±7 
Submandibula
r 
gland 
255±5 252±8 252±10 273±6 
Sublingual 
gland 
48.4±4.5 48.5±0.8 46.0±1.2 54.9±1.7 
Salivary volume (mg/10-20min) 296±13 345±15 180±12 313±6 
Salivary protein concentration 
(mg/ml)  
9.67±0.11 9.50±0.09 7.64±0.68 9.99±0.46 
Data represent means ± SE (n=6). 
*p<0.05, **p<0.01 
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 Table 2. Genes up-regulated by >1.5-fold in SLGs from whey-drinking rats compared to those 
from water-drinking rats 
 
Genedescription Genesymbol 
Fold  
change 
Accession no. p-value FDR 
Major salivary protein genes 
Proline-rich proteins   
proline rich, lacrimal 1 Prol1 8.66 NM_133513 0.035 0.102# 
proline rich protein 2 Prp2 7.20 NM_001013211 0.060 0.102# 
proline-rich proteoglycan 1 Prpg1 3.06 NM_172064 0.017 0.102# 
proline-rich protein 15  Prp15 2.81 NM_012632 0.033 0.102# 
proline-rich protein BstNI subfamily 
1 
Prb1 1.72 M83567 0.175 0.196 
Cystatin proteinase inhibitor    
cystatin S Cyss 25.85 NM_198685 0.003 0.054# 
von Ebners gland protein 2 Vegp2 2.16 NM_053574 0.075 0.103# 
Amylase   
amylase, alpha 1A (salivary) Amy1a 3.27 NM_001010970 0.056 0.102# 
Salivary gland homeostasis protein genes     
Serine endopeptidases   
tonin Ton 15.66 NM_012677 0.052 0.102# 
kallikrein, submaxillary gland S3 Klks3 11.44 NM_175759 0.060 0.102# 
T-kininogenase Klk1c10 10.63 NM_001135173 0.071 0.102# 
kallikrein 1 Klk1 6.90 NM_001005382 0.062 0.102# 
kallikrein 1-like peptidase Klk1l 3.92 NM_012593 0.041 0.102# 
glandular kallikrein 11 Gk11 2.81 NM_001003977 0.142 0.162 
kallikrein 1-related peptidase b21 Klk1b21 2.17 NM_001013067 0.050 0.102# 
kallikrein 1-related peptidase c10-
like 2 
Klk1c10l2 1.62 L33840 0.069 0.102# 
Androgen related protein    
submaxillary gland androgen 
regulated protein 3A 
Smr3a 10.68 NM_001017497 0.071 0.102# 
androgen binding protein, alpha Abpa 4.98 NM_001100859 0.035 0.102# 
ABP beta LOC494538 4.71 GU269241 0.033 0.102# 
similar to androgen-binding protein 
eta 
LOC689199 1.73 NM_001170457 0.181 0.196 
androgen binding protein zeta Abpz 1.68 GU269242 0.190 0.200 
Transcriptional regulator    
transcription factor AP-2 beta Tcfap2b 2.13 NM_001106896 0.003 0.054# 
Signal transduction    
phosphodiesterase 3A, cGMP 
inhibited 
Pde3a 1.67 NM_017337 0.002 0.054# 
Minor salivary protein genes 
prolactin induced protein Pip 6.38 NM_022708 0.035 0.102# 
glutamine/glutamic acid-rich protein 
A  
Grpca 5.91 NM_181440 0.055 0.102# 
cytidine monophosphate-N-
acetylneuraminic acid hydroxylase 
Cmah 4.96 NM_001024273 0.079 0.105 
alpha-2u globulin PGCL4  Obp3 4.59 NM_147215 0.050 0.102# 
alpha-2u globulin PGCL2  LOC298116 4.45 NM_001033959 0.051 0.102# 
alpha-2u globulin PGCL3  LOC259244 4.37 NM_147212 0.057 0.102# 
salivary protein 1 Spt1 4.35 NM_019171 0.069 0.102# 
major urinary protein 5  Mup5 4.35 NM_203325 0.044 0.102# 
major urinary protein 4  Mup4 4.24 NM_198784 0.050 0.102# 
alpha-2u globulin PGCL5  LOC259245 4.08 NM_147213 0.049 0.102# 
variable coding sequence A1 Vcsa1 3.83 NM_012684 0.102 0.121 
alpha2u globulin LOC298111 3.73 NM_001024248 0.051 0.102# 
variable coding sequence A2  Vcsa2 3.54 NM_198729 0.021 0.102# 
alpha-2u globulin PGCL1  LOC259246 3.30 NM_147214 0.069 0.102# 
ABO blood group Abo 3.04 NM_023094 0.088 0.112 
chemokine (C-X-C motif) ligand 13 Cxcl13 1.63 NM_001017496 0.293 0.293 
lactoperoxidase Lpo 1.60 NM_001105829 0.010 0.102# 
Other genes   
RGD1559532  RGD1559532 3.43 NM_001024983 0.036 0.102# 
carbonic anhydrase 6 Car6 2.77 NM_001134841 0.020 0.102# 
claudin 22 Cldn22 2.66 NM_001110143 0.081 0.106 
triadin Trdn 2.27 NM_021666 0.100 0.122 
glycosylation dependent cell 
adhesion molecule 1 
Glycam1 2.09 NM_012794 0.265 0.270 
epidermal growth factor Egf 1.91 NM_012842 0.038 0.102# 
angiotensinogen (serpin peptidase 
inhibitor, clade A, member 8) 
Agt 1.87 NM_134432 0.194 0.201 
similar to lipase-like, ab-hydrolase 
domain containing 2 
RGD1565682 1.83 XM_008760354                          0.033 0.102#
carbonic anhydrase II Car2 1.77 NM_019291 0.051 0.102# 
similar to 9530008L14Rik protein RGD1305679 1.72 BC088287 0.023 0.102# 
similar to protein of unknown 
function 
RGD1566243 1.69 NM_001134635 0.037 0.102# 
melanoma inhibitory activity Mia 1.64 NM_030852 0.039 0.102# 
solute carrier family 6 
(neurotransmitter transporter) 
Slc6a14 1.63 NM_001037544 0.096 0.119 
solute carrier family 37 (glycerol-3-
phosphate transporter) 
Slc37a2 1.55 NM_001191994 0.073 0.103# 
coiled-coil domain containing 129 Ccdc129 1.53 NM_001191973 0.042 0.102# 
scavenger receptor class A, member 
3 
Scara3 1.50 NM_001108870 0.135 0.157 
      
#FDR≦0.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Genes dowm-regulated by >1.5-fold in SLGs from whey-drinking rats compared to those 
from water-drinking rats 
 
Genedescription Genesymbol 
Fold 
change 
Accession no. p-value FDR 
Lipid metabilism related genes   
similar to fatty aldehyde 
dehydrogenase-like 
LOC688778 -2.85 XM_008760188             0.002 0.000# 
prostaglandin D receptor-like  Ptgdrl -1.51 NM_022241 0.019 0.037# 
Transcriptional regulator related genes   
forkhead box P2 Foxp2 -1.55 XM_002729284 0.003 0.013# 
Cancer related genes   
hemopexin Hpx -1.58 NM_053318 0.072 0.090# 
protease, serine, 37 Prss37 -1.52 NM_001108625 0.005 0.016# 
Signal transduction genes   
synaptosomal-associated 
protein 25 
Snap25 -2.18 NM_030991 0.118 0.131 
immediate early response 3 Ier3 -1.53 NM_212505 0.007 0.016# 
Immune response related 
genes 
  
mCG127631-like LOC366766 -1.71   0.021 0.041# 
pre-B lymphocyte 3-like LOC682821 -1.51 NW_001084890           0.301 0.301 
Senescence related genes   
cysteine-rich, angiogenic 
inducer, 61 
Cyr61 -1.96 NM_031327 0.029 0.408 
#FDR≦0.1 
 
 
 
 
 
 
 
 
 
 
 Table ４. List of overlapping genes in a Venn diagram 
    
Genedescription Genesymbol 
Fold  
change 
Accession no. 
Secretory proteins     
cystatin S Cyss 25.85 NM_198685 
alpha-2u globulin PGCL1  LOC259246 3.30 NM_147214 
alpha-2u globulin PGCL2  LOC298116 4.45 NM_001033959 
alpha-2u globulin PGCL3  LOC259244 4.37 NM_147212 
alpha-2u globulin PGCL4  Obp3 4.59 NM_147215 
alpha-2u globulin PGCL5  LOC259245 4.08 NM_147213 
major urinary protein 4  Mup4 4.24 NM_198784 
major urinary protein 5  Mup5 4.35 NM_203325 
Homeostasis proteins     
kallikrein 1 Klk1 6.90 NM_001005382 
androgen binding protein, alpha Abpa 4.98 NM_001100859 
transcription factor AP-2 beta Tcfap2b 2.13 NM_001106896 
similar to fatty aldehyde dehydrogenase-
like 
LOC688778 -2.85 XM_008760188 
pre-B lymphocyte 3-like LOC682821 -1.51 NW_001084890 
    
 
